Co-Diagnostics wins dismissal of class action lawsuit

Co-Diagnostics (CODX) announced that on March 4, the Securities & Governance Litigation Team at BakerHostetler, the legal firm retained to represent the company, won complete dismissal on summary judgment of a Section 10(b) securities class action that had been pending against the company in the United States District Court for the District of Utah. See Gelt Trading, Ltd. v. Co-Diagnostics, Inc. et al., Case No. 2:20-cv-00368-JNP-DBP (D. Utah). The company regards this dismissal as a tremendous victory and is optimistic about its chances of prevailing in any appeal plaintiff might file. The company looks forward to putting the matter behind it, as it moves ahead with its mission of increasing the availability of high-quality molecular diagnostics on a global scale.